Access cutting-edge vitiligo treatment through this clinical trial at a research site in Rockville. Study-provided care at no cost to qualified participants.
Access vitiligo specialists in Rockville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related vitiligo treatment provided free
This study is to evaluate how safe and effective ritlecitinib is in participants with non-segmental vitiligo (NSV). Ritlecitinib is studied in patients with non-segmental vitiligo. Vitiligo is a chronic acquired depigmentation disorder characterized by well-defined pale white patches of skin. Non-segmental vitiligo is an autoimmune disorder and is the focus of this study. The study will show: * if the repigmentation (the recovery of pigmentation) achieved in study B7981040 (also called the "p
Sponsor: Pfizer
Check if you qualify for this vitiligo clinical trial in Rockville, MD
If you're searching for vitiligo treatment options in Rockville, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rockville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced vitiligo specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.